Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease. (A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope.) Nanomedicine technology inspired by platelet-derived microparticles (PMPs). PMPs, initially reported by Wolf in the 1960s as ‘platelet dust,’ these membrane fragments shed from activated platelets. This type of delivery system’s advantages are that there are no detrimental side effects, and the practitioners can use a hyper-targeting system to get the drugs exactly where they are needed.
Practitioners could also utilize this type of technology to accelerate regenerative therapies, such as those for the bone, vascular, heart, cartilage, bladder, and brain tissue that aims to restore, maintain or enhance tissues and hence organ functions. Various nanostructured polymers and metals (alloys) have been investigated for their bio (and cyto) compatibility properties that aim to restore, maintain or enhance tissues and hence organ functions.
In this episode:
- Learn the fundamental dynamics of nanotechnology
- The use of hyper-targeting using platelet microparticles that will transfer their cargo to endothelial cells, macrophages, and neutrophils
- How it would be possible to use nanotechnology in regenerative therapies
- The synergy of photo-synthesizers & nanotechnology to enhance treatments for autoimmune and regenerative medicine
- The role of free radicals in oxidation in controlling cancer
More about Dr. Salaheldin Halasa MD
Dr. Halasa is involved in developing new formulations and protocols for Photodynamic Cancer Therapy and Photoactivated Stem Cell Therapies. Dr. Halasa is the Founder and CEO of Nitromedicine LLC. Nitromedicine LLC is a successful US consultation company established in 2014 by a team of medical professionals with years of experience in custom prescription formulations and protocols related to nitric oxide therapy, laser therapy, electrotherapy, stem cell therapy, nanotherapy, redox therapy, hormonal therapy, cryotherapy, and platelet-rich plasma therapy. These inventions are intended to provide medical treatments for oxidative stress-related diseases such as degenerative diseases, immunological diseases, chronic infectious diseases, cancers, and a broad range of unmet medical needs involving chronic inflammation with an emphasis on pain management.
Dr. Halasa earned his medical degree at Tripoli University in Tripoli, Libya, in 1998.
He was a researcher in Immuno-Therapy at Baylor University in Texas, a Clinical associate at compassionate pain management in Delaware, and has published Nitromedicine articles with Dr. Hamblin at Wellman Center for Photomedicine in Massachusetts.
He is now the founder of Chronic Diseases Prevention and Management Centers, academy of oxidative Disorders, and Nitromedicine.
Dr. Halasa is a frequent guest speaker at renowned venues such as International Society for Optical Engineering, American Society for Laser Medicine and Surgery, Nitric Oxide Society, American Academy of Anti-Aging Medicine, ISLA, Florida academy of pain medicine Photo-biology society, Boston bio life conferences and American academy of stem cells physicians, American Osteopathic Society of Rheumatic Diseases and academy of oxidative stress disorders.
Connect with Dr. Halasa
In an avid pursuit of worldly knowledge, Dr. Michael Karlfeldt conducts weekly interviews on HealthMade Radio with global integrative health experts, scientists, philanthropists, and entrepreneurs. These interviews are shared on our page to promote a community of health and education.
Health is what you make it!